Swiss National Bank’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-393,085
| Closed | -$282K | – | 2741 |
|
|
2022
Q1 | $282K | Buy |
393,085
+28,300
| +8% | +$20.3K | ﹤0.01% | 2663 |
|
|
2021
Q4 | $824K | Buy |
364,785
+28,700
| +9% | +$64.8K | ﹤0.01% | 2545 |
|
|
2021
Q3 | $968K | Buy |
336,085
+14,600
| +5% | +$42.1K | ﹤0.01% | 2451 |
|
|
2021
Q2 | $1.22M | Buy |
321,485
+7,700
| +2% | +$29.2K | ﹤0.01% | 2388 |
|
|
2021
Q1 | $1.06M | Buy |
313,785
+9,700
| +3% | +$32.8K | ﹤0.01% | 2325 |
|
|
2020
Q4 | $851K | Hold |
304,085
| – | – | ﹤0.01% | 2358 |
|
|
2020
Q3 | $763K | Buy |
304,085
+51,800
| +21% | +$130K | ﹤0.01% | 2231 |
|
|
2020
Q2 | $3.43M | Buy |
252,285
+102,300
| +68% | +$1.39M | ﹤0.01% | 1378 |
|
|
2020
Q1 | $1.14M | Buy |
149,985
+2,100
| +1% | +$15.9K | ﹤0.01% | 1753 |
|
|
2019
Q4 | $935K | Buy |
147,885
+4,100
| +3% | +$25.9K | ﹤0.01% | 2174 |
|
|
2019
Q3 | $564K | Buy |
143,785
+5,200
| +4% | +$20.4K | ﹤0.01% | 2321 |
|
|
2019
Q2 | $671K | Hold |
138,585
| – | – | ﹤0.01% | 2315 |
|
|
2019
Q1 | $1.14M | Sell |
138,585
-5,900
| -4% | -$48.3K | ﹤0.01% | 1997 |
|
|
2018
Q4 | $799K | Buy |
144,485
+66,385
| +85% | +$367K | ﹤0.01% | 2129 |
|
|
2018
Q3 | $690K | Hold |
78,100
| – | – | ﹤0.01% | 2321 |
|
|
2018
Q2 | $779K | Hold |
78,100
| – | – | ﹤0.01% | 2303 |
|
|
2018
Q1 | $744K | Buy |
78,100
+13,800
| +21% | +$131K | ﹤0.01% | 2247 |
|
|
2017
Q4 | $956K | Buy |
+64,300
| New | +$956K | ﹤0.01% | 2118 |
|
|
2015
Q2 | – | Sell |
-17,200
| Closed | -$191K | – | 2582 |
|
|
2015
Q1 | $191K | Hold |
17,200
| – | – | ﹤0.01% | 2489 |
|
|
2014
Q4 | $200K | Buy |
+17,200
| New | +$200K | ﹤0.01% | 2505 |
|